Company: Cheetah Medical
Location: Tel Aviv, Israel, Vancouver, WA
Cheetah Medical's lead product is its NICOM noninvasive cardiac output and hemodynamic monitoring system to deliver continuous, accurate, noninvasive cardiac output, according to its website. It has FDA clearance and CE Mark approval for its system, the only non-invasive hemodynamic and cardiac output monitor.
Earlier this month, results from a study the company says validates the system for use in surgery to guide fluid management were presented at the 2011 American Society of Anesthesiologists Annual Meeting in Chicago. According to the company, NICOM can provide accurate continuous hemodynamic information that can be used to guide fluid management and support goal-directed therapy.
Cheetah closed a $20 million financing round in early 2010. The financing was led by Ascension Health Ventures and included Robert Bosch Venture Capital, MVM Life Science Partners and existing investors.